What's new

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 19, Status: Authorised

May 19, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 19, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim...

Next Article

Human medicines European public assessment report (EPAR): Sitagliptin / Metformi...

Related Posts

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0

Clinical Trials Information System (CTIS): Walk-in clinic - May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 May 2025, 16:00 (CEST) to 14 May 2025, 17:00 (CEST)

Clinical Trials Information System (CTIS): Walk-in clin...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Aqumeldi, Enalapril maleate, Date of authorisation: 15/11/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0